Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Journal of Drug Issues
|
August 6, 2013
Poly-Drug Use among Ecstasy Users: Separate, Synergistic, and Indiscriminate Patterns
M Boeri, C Sterk, M Bahora, et al.
Transfusion
|
March 1, 1991
Inhibition of in vitro adherence of antibody-coated red cells to monocytes by the dialyzable leukocyte extract
P Rebulla, F Tedesco, O Radillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 7, 2019
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
U Pastorino, M Silva, S Sestini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2019
Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening
U Pastorino, N Sverzellati, S Sestini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 3, 2019
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
U Pastorino, M Silva, S Sestini, et al.
Cell Death & Disease
|
December 16, 2014
Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction
O Fortunato, M Boeri, M Moro, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
April 25, 2021
Guiding the rational design of patient-centred drug trials in Cystic Fibrosis: A Delphi study
R Dobra, J S Elborn, S Madge, et al.
Osteoarthritis and Cartilage
|
July 12, 2020
Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment
D Turk, M Boeri, L Abraham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2022
Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial
U Pastorino, M Boeri, S Sestini, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Journal of Drug Issues
|
August 6, 2013
Poly-Drug Use among Ecstasy Users: Separate, Synergistic, and Indiscriminate Patterns
M Boeri, C Sterk, M Bahora, et al.
Transfusion
|
March 1, 1991
Inhibition of in vitro adherence of antibody-coated red cells to monocytes by the dialyzable leukocyte extract
P Rebulla, F Tedesco, O Radillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 7, 2019
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
U Pastorino, M Silva, S Sestini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2019
Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening
U Pastorino, N Sverzellati, S Sestini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 3, 2019
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy
U Pastorino, M Silva, S Sestini, et al.
Cell Death & Disease
|
December 16, 2014
Mir-660 is downregulated in lung cancer patients and its replacement inhibits lung tumorigenesis by targeting MDM2-p53 interaction
O Fortunato, M Boeri, M Moro, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
April 25, 2021
Guiding the rational design of patient-centred drug trials in Cystic Fibrosis: A Delphi study
R Dobra, J S Elborn, S Madge, et al.
Osteoarthritis and Cartilage
|
July 12, 2020
Patient preferences for osteoarthritis pain and chronic low back pain treatments in the United States: a discrete-choice experiment
D Turk, M Boeri, L Abraham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 29, 2022
Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial
U Pastorino, M Boeri, S Sestini, et al.
Page
of 1